Patents by Inventor Javier Ochoa-Reparaz

Javier Ochoa-Reparaz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160158269
    Abstract: The present invention embraces nutraceutical compositions containing isolated Bacteroides fragilis capsular polysaccharide A for use in methods of preventing or treating multiple sclerosis.
    Type: Application
    Filed: February 23, 2016
    Publication date: June 9, 2016
    Inventors: Lloyd H. Kasper, Javier Ochoa-Reparaz
  • Publication number: 20160143941
    Abstract: The present invention embraces nutraceutical compositions containing isolated Bacteroides fragilis capsular polysaccharide A for use in methods of preventing or treating multiple sclerosis.
    Type: Application
    Filed: December 14, 2015
    Publication date: May 26, 2016
    Applicant: Trustees of Dartmouth College
    Inventors: Lloyd H. Kasper, Javier Ochoa-Reparaz
  • Publication number: 20140030807
    Abstract: Disclosed is the use of isolated Bacteroides fragilis capsular polysaccharide A in a method for stimulating FoxP3+ regulatory T cell expression of CD39.
    Type: Application
    Filed: July 19, 2011
    Publication date: January 30, 2014
    Applicant: TRUSTEES OF DARTMOUTH COLLEGE
    Inventors: Lloyd H. Kasper, Javier Ochoa-Reparaz
  • Patent number: 8586029
    Abstract: The present invention is a method for preventing or treating an immune-relevant disease by modulating commensal microbiota populations via antibiotics, exogenous microbiota and/or probiotics.
    Type: Grant
    Filed: June 3, 2009
    Date of Patent: November 19, 2013
    Assignee: Trustees of Dartmouth College
    Inventors: Lloyd H. Kasper, Javier Ochoa-Repáraz
  • Patent number: 8580278
    Abstract: The present invention embraces nutraceutical compositions containing isolated Bacteroides fragilis capsular polysaccharide A for use in methods of preventing or treating multiple sclerosis.
    Type: Grant
    Filed: June 17, 2011
    Date of Patent: November 12, 2013
    Assignee: Trustees of Dartmouth College
    Inventors: Lloyd H. Kasper, Javier Ochoa-Reparaz
  • Publication number: 20120094950
    Abstract: The present invention embraces nutraceutical compositions containing isolated Bacteroides fragilis capsular polysaccharide A for use in methods of preventing or treating multiple sclerosis.
    Type: Application
    Filed: June 17, 2011
    Publication date: April 19, 2012
    Applicant: Trustees of Dartmouth College
    Inventors: Lloyd H. Kasper, Javier Ochoa-Reparaz
  • Publication number: 20110086011
    Abstract: The present invention is a method for preventing or treating an immune-relevant disease by modulating commensal microbiota populations via antibiotics, exogenous microbiota and/or probiotics.
    Type: Application
    Filed: June 3, 2009
    Publication date: April 14, 2011
    Inventors: Lloyd H. Kasper, Javier Ochoa-Repáraz
  • Publication number: 20110009360
    Abstract: The present invention embraces nutraceutical compositions containing isolated Bacteroides fragilis capsular polysaccharide A for use in methods of preventing or treating multiple sclerosis.
    Type: Application
    Filed: July 20, 2010
    Publication date: January 13, 2011
    Inventors: Lloyd H. Kasper, Javier Ochoa-Reparaz
  • Publication number: 20100311686
    Abstract: The present invention embraces nutraceutical compositions containing isolated Bacteroides fragilis capsular polysaccharide A for use in methods of preventing or treating multiple sclerosis.
    Type: Application
    Filed: November 3, 2009
    Publication date: December 9, 2010
    Inventors: Lloyd H. Kasper, Javier Ochoa-Reparaz